- Home
- MSEX vs XNCR Comparison
MSEX vs XNCR Comparison
Compare MSEX & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MSEX | XNCR |
|---|---|---|
| Founded | 1897 | 1997 |
| Country | United States | United States |
| Employees | 395 | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 881.9M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | MSEX | XNCR |
|---|---|---|
| Price | $54.19 | $11.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $61.33 | $22.33 |
| AVG Volume (30 Days) | 91.1K | ★ 634.9K |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.77% | N/A |
| EPS Growth | N/A | ★ 65.36 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $125,576,000.00 |
| Revenue This Year | $10.60 | N/A |
| Revenue Next Year | $10.94 | $4.80 |
| P/E Ratio | $22.68 | ★ N/A |
| Revenue Growth | N/A | ★ 13.65 |
| 52 Week Low | $44.94 | $6.92 |
| 52 Week High | $62.18 | $18.69 |
Technical Indicators
Market Signals| Indicator | MSEX | XNCR |
|---|---|---|
| Relative Strength Index (RSI) | 63.35 | 50.11 |
| Support Level | $49.91 | $10.87 |
| Resistance Level | $54.92 | $12.65 |
| Average True Range (ATR) | 1.21 | 0.53 |
| MACD | 0.28 | 0.06 |
| Stochastic Oscillator | 94.71 | 67.48 |
Price Performance
Historical ComparisonAbout MSEX Middlesex Water Company
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.